GCG and type 2 diabetes mellitus: The combined therapy of human UC derived-MSCs (hUC-MSCs) and liraglutide, a glucagon-like-peptide 1 (GLP1), additively inhibited beta-cell apoptosis in T2D model via suppressing the ASK1/JNK/BAX signaling [59].